AZD1222 US Phase III primary analysis confirms safety and efficacy

Positive high-level results from the primary analysis of the Phase III trial of AZD1222 in the US have confirmed vaccine...

March 25, 2021 | Thursday | News
Gavi board approves COVAX buffer for high-risk groups in humanitarian settings

The Board of Gavi, the Vaccine Alliance on March 23, 2021, has approved the COVAX Buffer to ensure access to C...

March 24, 2021 | Wednesday | News
CanSinoBIO's single-dose COVID-19 vaccine Convidecia™ receives approval in Hungary

CanSinoBIO Biologics Inc. announced that the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI) grant...

March 23, 2021 | Tuesday | News
Daiichi Sankyo starts Ph 1/2 trial for mRNA COVID-19 vaccine in Japan

Daiichi Sankyo Company, Limited has announced that it has started the first vaccinations in a phase 1/2 clinical trial i...

March 23, 2021 | Tuesday | News
Australia approves CSL - Seqirus to manufacture AstraZeneca COVID-19 vaccine

The Therapeutic Goods Administration (TGA) has approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in A...

March 22, 2021 | Monday | News
CEPI, HKU expand partnership for intranasal COVID-19 vaccine candidate

CEPI, the Coalition for Epidemic Preparedness Innovations, and the University of Hong Kong (HKU) have announced an exp...

March 19, 2021 | Friday | News
Daiichi Sankyo begins manufacture of the AstraZeneca COVID-19 Vaccine in Japan

Daiichi Sankyo Company, Ltd announced on March 12, 2021, that it has started manufacturing the AstraZeneca COVID-19 vacc...

March 17, 2021 | Wednesday | News
Takeda, IDT support manufacturing of J&J's COVID-19 vaccine

Takeda Pharmaceutical Company Limited has announced a reciprocal agreement with IDT Biologika GmbH (“IDT&rdqu...

March 16, 2021 | Tuesday | News
BioVaxys enters bioproduction agreement with Wuxi Biologics for COVID-19 vaccine

British Columbia-registered BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and...

March 16, 2021 | Tuesday | News
WHO grants EUL to J&J’s single-shot COVID-19 vaccine

Johnson & Johnson has announced that the World Health Organization (WHO) has issued emergency use listing (EUL) for ...

March 15, 2021 | Monday | News
Taiwan develops vaccine against all strains of influenza

Winter is the beginning of the annual influenza season, and every year, in its efforts to prepare the required vaccinati...

March 15, 2021 | Monday | News
EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU

EMA has recommended granting conditional marketing author...

March 12, 2021 | Friday | News
Zuellig Pharma launches eZVax, a vaccine management solution

Zuellig Pharma, a leading healthcare services provider in Asia has launched eZVax, a vaccine management solution that en...

March 11, 2021 | Thursday | News
EU supports Member States with additional 4 million BioNTech-Pfizer doses

The European Commission has reached an agreement with BioNTech-Pfizer for the supply of four million more doses of COVID...

March 10, 2021 | Wednesday | News
Italian firms sign agreement to produce Sputnik V in Europe

The Italian-Russian Chamber of Commerce (CCIR) holds an aim of contributing to the development of economic, commercial, ...

March 10, 2021 | Wednesday | News
Moderna to provide 13 M doses of COVID-19 vaccine to Philippines

Moderna, Inc has announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-1...

March 9, 2021 | Tuesday | News
Takeda to import & distribute Moderna’s vaccine in Japan

Moderna, Inc has announced that Takeda Pharmaceutical Co, Ltd submitted a new drug application to the Government of Japa...

March 8, 2021 | Monday | News
GC Pharma to distribute 40M doses of Moderna vaccine in South Korea

GC Pharma has announced that it will support Moderna and the government of the Republic of Korea in the distribution of ...

March 5, 2021 | Friday | News